Stem Cells Market Size To Exceed USD 17.79 billion by 2027

[150+ Pages Report] global stem cells market was evaluated at USD 9.3 billion in 2020 and is speculated to accrue USD 17.79 billion by 2027, growing at 8.61% CAGR between 2021-2027.

The stem cells market report covers a detailed analysis for the historic period 2017-2020, considering 2021 as the base year and forecast (growth) for 2021-2027.

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1118

This research report evaluates the stem cells market on a global and regional level. It offers a thorough analysis of the market revenue status, growth, future trends, and forecast of the global stem cells market for the period from 2017 to 2027.

Growth Factors

Since past few years, stem cells market is growing with the increasing investment in stem cell-based research by biopharmaceutical and pharmaceutical firm along with the success of regenerative medicines. Stem cells market is growth is backed by escalating number of clinical trials across the world. Some of the major factors driving the growth of the stem cells market include advancement in stem cell manufacturing technology as well as increasing harvest awareness regarding therapeutic potency. High occurrences of infections have steered the development of vaccines using various human diploid and non-tumorigenic cell lines.

Growing demands as well as awareness along with ongoing research and development of vaccines against different diseases are certain growth influencers of the stem cells market. Additionally, prevalence of chronic diseases will also fuel the market growth. Presence of advanced stem cells banking and availability of stem cells donor will significantly boost the market demand during upcoming years. Rigorous support of government via different initiatives aids stem cells banking to obtain significance. Increasing number of stem cells banks in emerging economies is further encouraging market penetration. Also, growing awareness about stem cell harvest which holds high potential in therapeutic and diagnosis field offers lucrative prospects to the market during impending years.

Intensifying prevalence of cancer worldwide is offering substantial boost to the growth of cancer stem cells market. As per the data published by World Health Organization, the global cancer implication is projected to have risen to around 18 million latest cases and around 9.2 million deaths in year 2018. Additionally, according to Cancer Research UK, the population enduring the cancer is anticipated to grow in near future.

Market Report Scope

For More Information or Customization Before Buying, Visit @ https://www.precedenceresearch.com/customization/1118

This report enables readers to make important decisions with regard to their business, with the help of a wealth of Information enclosed in the study. The report also provides the compound annual growth rate (CAGR) of the global stem cells market for the forecast period of 2021–2027. This data can help readers interpret quantitative growth aspects of the global market during the forecast period. It presents a wealth of information on key market dynamics, including drivers, market trends, and challenges, as well as the structure of the global market across the globe.

The report analyzes the historical and present-day scenario of the global stem cells market to accurately gauge its growth potential. The study presents detailed information about important growth factors, restraints, and key trends that are creating the landscape for growth of the global market in order to identify opportunities for stakeholders.

Key Highlights

• Increasing prevalence of chronic diseases significantly drive the stem cells market across the globe.
• Rising Stem cell-based research and development, government initiatives and investment by pharmaceutical firms in stem cells fuel the growth of the stem cells market.
• Growing donors of stem cells and advanced stem cell banking will further propel the market growth.
• Huge success of regenerative medicines and increasing adoption of stem cell therapies are the factors projected to positively impact the stem cells market over the forecast period.
• Budding regulatory frameworks for stem cell therapeutics in Europe and the U.S.is flourishing the stem cell technology acceptance
• The cell acquisition technology dominated the stem cells market in 2019
• The Allogeneic therapy acquired largest market share among different therapy segments in 2019
• North America held the largest share in the market and is anticipated to continue its dominance over the forecast period due to existence of organized and developed healthcare systems which uplift research and development in the U.S. and Canada.
• Asia Pacific is likely to grow with the highest Compound Annual Growth Rate (CAGR) owing to wide usage of stem cells in regenerative medicines particularly in the sector of dermatology.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1118

Competition Landscape

In the final section of the research report, Precedence Research provided the global stem cells market structure and a detailed competition landscape to provide a dashboard view of key players operating in the global market along with their business strategies to report audiences. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the value chain of the market.

Some of the major players in the stem cells market include:

• STEMCELL Technologies, Inc.
• Osiris Therapeutics, Inc.
• Cynata Therapeutics
• Human Longevity, Inc.
• Advanced Cell Technology, Inc.
• BIOTIME, Inc.
• Mesoblast Limited
• Promethera Biosciences S.A. / N.V.
• Merck Group
• Takara Bio Group

Market Segmentation

By Product

• Adult Stem Cells
  • Neuronal Stem Cells
  • Mesenchymal Stem Cells
  • Dental Stem Cells
  • Umbilical Cord Stem Cells
  • Adipose-derived Stem Cells
  • HematopoieticStem Cells
  • Dedifferentiated fat (DFAT) Cells
  • Other ASC’s
• Very Small Embryonic Like Stem Cells
• Human Embryonic Stem Cells
• Induced Pluripotent Stem Cells

By Application

• Regenerative Medicine
  • Neurology
  • Oncology
  • Hematology
  • Injuries
  • Orthopedics
  • Incontinence
  • Diabetes
  • Liver Disorder
  • Others
• Drug Discovery and development

By Technology

• Cell Acquisition
  • Apheresis
  • Bone Marrow Harvest
  • Umbilical Blood Cord
• Cryopreservation
• Cell production
  • Therapeutic Cloning
  • Cell Culture
  • In-Vitro fertilization
  • Isolation
• Expansion and Sub-Culture

By Therapy

• Allogenic Stem Cell Therapy
• Autologous Stem Cell Therapy

Regional Segmentation

– North America (U.S. and Canada)

 – Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

 – Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)

 – Latin America (Brazil and Rest of Latin America)

– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

• Market estimate for 2020
• Average selling price (ASP) per region for specific product type
• Filtrations and assortment of gathered data, to estimate the base year (2021) market size for the country
• Gathering data from company websites, annual reports, white papers, financial reports, broker reports, investor presentations, and SEC filings
• National government documents, statistical databases
• News articles, press releases, and webcasts specific to companies operating in the market
• Country wise analysis through internal and external proprietary databases, and relevant patent and regulatory databases
• Determination of market penetration by country

Most Asked Questions –

What was the market size value of the stem cells in 2020?

What is the expected market size by 2027?

What is the stem cells market growth?

What are the key factors that positively influence market growth?

Who are the prominent players in the stem cells market?

Why Buy this Report?

The purpose of Precedence Research’s stem cells market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Stem Cell Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Stem Cell Market

5.1. Covid-19: Stem Cell Industry Impact
5.2. Stem Cell Business Impact Assessment: Covid-19
5.2.1. Supply Chain Challenges/Disruption
5.2.2. Market Trends and Stem Cell Opportunities in the COVID-19 Landscape
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Stem Cell Manufacturers to deal with Covid-19 Pandemic Scenario

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition

Chapter 7. Global Stem Cell Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Stem Cell Market Revenue by Manufacturer (2015-2020)
7.1.1.2. Stem Cell Market Revenue Market Share by Manufacturer (2015-2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Capacity Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers

Chapter 8. Global Stem Cell Market, By Product Type

8.1. Stem Cell Market, by Product Type, 2016-2027
8.1.1. Adult Stem Cells
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Very Small Embryonic Like Stem Cells
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Human Embryonic Stem Cells
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Induced Pluripotent Stem Cells
8.1.4.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global Stem Cell Market, By Application

9.1. Stem Cell Market, by Application, 2016-2027
9.1.1. Regenerative Medicine
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Drug Discovery and development
9.1.2.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global Stem Cell Market, By Technology

10.1. Stem Cell Market, By Technology, 2016-2027
10.1.1. Cell Acquisition
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Cryopreservation
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Cell production
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Expansion and Sub-Culture
10.1.4.1. Market Revenue and Forecast (2016-2027)

Chapter 11. Global Stem Cell Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Product (2016-2027)
11.1.2. Market Revenue Forecast by Application (2016-2027)
11.1.3. Market Revenue Forecast By Technology (2016-2027)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2016-2027)
11.1.4.2. Market Revenue Forecast (2016-2027)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2016-2027)
11.1.5.2. Market Revenue Forecast (2016-2027)
11.2. Europe
11.2.1. Market Revenue Forecast by Product (2016-2027)
11.2.2. Market Revenue Forecast by Application (2016-2027)
11.2.3. Market Revenue Forecast By Technology (2016-2027)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2016-2027)
11.2.4.2. Market Revenue Forecast (2016-2027)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2016-2027)
11.2.5.2. Market Revenue Forecast (2016-2027)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2016-2027)
11.2.6.2. Market Revenue Forecast (2016-2027)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2016-2027)
11.2.7.2. Market Revenue Forecast (2016-2027)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product (2016-2027)
11.3.2. Market Revenue Forecast by Application (2016-2027)
11.3.3. Market Revenue Forecast By Technology (2016-2027)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2016-2027)
11.3.4.2. Market Revenue Forecast (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2016-2027)
11.3.5.2. Market Revenue Forecast (2016-2027)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2016-2027)
11.3.6.2. Market Revenue Forecast (2016-2027)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2016-2027)
11.3.7.2. Market Revenue Forecast (2016-2027)
11.4. LATAM
11.4.1. Market Revenue Forecast by Product (2016-2027)
11.4.2. Market Revenue Forecast by Application (2016-2027)
11.4.3. Market Revenue Forecast by Technology (2016-2027)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2016-2027)
11.4.4.2. Market Revenue Forecast (2016-2027)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2016-2027)
11.4.5.2. Market Revenue Forecast (2016-2027)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product (2016-2027)
11.5.2. Market Revenue Forecast by Application (2016-2027)
11.5.3. Market Revenue Forecast by Technology (2016-2027)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2016-2027)
11.5.4.2. Market Revenue Forecast (2016-2027)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2016-2027)
11.5.5.2. Market Revenue Forecast (2016-2027)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2016-2027)
11.5.6.2. Market Revenue Forecast (2016-2027)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2016-2027)
11.5.7.2. Market Revenue Forecast (2016-2027)

Chapter 12. Company Profiles

12.1. Company 1
12.1.1. Company Overview, Business Information, Manufacturing Area
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue and Gross Margin (2015-2020)
12.1.4. Recent Developments and Strategies
12.2. STEMCELL Technologies, Inc.
12.2.1. Company Overview, Business Information, Manufacturing Area
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue and Gross Margin (2015-2020)
12.2.4. Recent Developments and Strategies
12.3. Osiris Therapeutics, Inc.
12.3.1. Company Overview, Business Information, Manufacturing Area
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue and Gross Margin (2015-2020)
12.3.4. Recent Developments and Strategies
12.4. Cynata Therapeutics
12.4.1. Company Overview, Business Information, Manufacturing Area
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue and Gross Margin (2015-2020)
12.4.4. Recent Developments and Strategies
12.5. Human Longevity, Inc.
12.5.1. Company Overview, Business Information, Manufacturing Area
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue and Gross Margin (2015-2020)
12.5.4. Recent Developments and Strategies
12.6. Advanced Cell Technology, Inc.
12.6.1. Company Overview, Business Information, Manufacturing Area
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue and Gross Margin (2015-2020)
12.6.4. Recent Developments and Strategies
12.7. BIOTIME, Inc.
12.7.1. Company Overview, Business Information, Manufacturing Area
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue and Gross Margin (2015-2020)
12.7.4. Recent Developments and Strategies
12.8. Mesoblast Limited
12.8.1. Company Overview, Business Information, Manufacturing Area
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue and Gross Margin (2015-2020)
12.8.4. Recent Developments and Strategies
12.9. Promethera Biosciences S.A. / N.V.
12.9.1. Company Overview, Business Information, Manufacturing Area
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue and Gross Margin (2015-2020)
12.9.4. Recent Developments and Strategies
12.10. Merck Group
12.10.1. Company Overview, Business Information, Manufacturing Area
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue and Gross Margin (2015-2020)
12.10.4. Recent Developments and Strategies
12.11. Takara Bio Group
12.11.1. Company Overview, Business Information, Manufacturing Area
12.11.2. Product Portfolio Analysis
12.11.2.1. Product Details, Specification, Application
12.11.3. Revenue and Gross Margin (2015-2020)
12.11.4. Recent Developments and Strategies
12.12. Company 12
12.12.1. Company Overview, Business Information, Manufacturing Area
12.12.2. Product Portfolio Analysis
12.12.2.1. Product Details, Specification, Application
12.12.3. Revenue and Gross Margin (2015-2020)
12.12.4. Recent Developments and Strategies

Chapter 13. Research Methodology

13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1118

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: mailto:sales@precedenceresearch.com

For Latest Update Follow Us:

https://www.linkedin.com/company/precedence-research/

https://www.facebook.com/precedenceresearch/

https://twitter.com/Precedence_R